Confirmed 0 9 0 9 O
diagnosis 10 19 10 19 O
of 20 22 20 22 O
MDS 23 26 23 26 B-cancer
, 26 27 26 27 O
CMML 28 32 28 32 B-cancer
, 32 33 32 33 O
or 34 36 34 36 O
AML 37 40 37 40 B-cancer

Diagnosis 0 9 41 50 O
of 10 12 51 53 O
a 13 14 54 55 O
core 15 19 56 60 O
binding 20 27 61 68 O
factor 28 34 69 75 O
leukemia 35 43 76 84 B-cancer
( 44 45 85 86 O
t(8;21 45 51 86 92 O
) 51 52 92 93 O
, 52 53 93 94 O
t(16;16 54 61 95 102 O
) 61 62 102 103 O
or 63 65 104 106 O
inv(16 66 72 107 113 O
) 72 73 113 114 O
) 73 74 114 115 O

Eastern 0 7 116 123 B-clinical_variable
Cooperative 8 19 124 135 I-clinical_variable
Oncology 20 28 136 144 I-clinical_variable
Group 29 34 145 150 I-clinical_variable
( 35 36 151 152 I-clinical_variable
ECOG 36 40 152 156 I-clinical_variable
) 40 41 156 157 I-clinical_variable
performance 42 53 158 169 I-clinical_variable
score 54 59 170 175 I-clinical_variable
of 60 62 176 178 O
0 63 64 179 180 B-lower_bound
- 64 65 180 181 O
2 65 66 181 182 B-upper_bound

Family 0 6 183 189 O
history 7 14 190 197 O
of 15 17 198 200 O
Leber 18 23 201 206 B-chronic_disease
Hereditary 24 34 207 217 I-chronic_disease
Optic 35 40 218 223 I-chronic_disease
Neuropathy 41 51 224 234 I-chronic_disease
, 51 52 234 235 O
Autosomal 53 62 236 245 B-chronic_disease
Dominant 63 71 246 254 I-chronic_disease
Optic 72 77 255 260 I-chronic_disease
Atrophy 78 85 261 268 I-chronic_disease
, 85 86 268 269 O
Late 87 91 270 274 B-chronic_disease
- 91 92 274 275 I-chronic_disease
Onset 92 97 275 280 I-chronic_disease
Retinal 98 105 281 288 I-chronic_disease
Degeneration 106 118 289 301 I-chronic_disease
, 118 119 301 302 O
Familial 120 128 303 311 B-chronic_disease
Dysautonomia 129 141 312 324 I-chronic_disease
or 142 144 325 327 O
other 145 150 328 333 O
hereditary 151 161 334 344 O
mitochondrial 162 175 345 358 B-chronic_disease
disease 176 183 359 366 I-chronic_disease
, 183 184 366 367 O
unless 185 191 368 374 O
the 192 195 375 378 O
causative 196 205 379 388 O
mutation(s 206 216 389 399 O
) 216 217 399 400 O
in 218 220 401 403 O
the 221 224 404 407 O
family 225 231 408 414 O
have 232 236 415 419 O
been 237 241 420 424 O
determined 242 252 425 435 O
and 253 256 436 439 O
the 257 260 440 443 O
participant 261 272 444 455 O
has 273 276 456 459 O
tested 277 283 460 466 O
negative 284 292 467 475 O
for 293 296 476 479 O
the 297 300 480 483 O
mutation(s 301 311 484 494 O
) 311 312 494 495 O

For 0 3 496 499 O
AML 4 7 500 503 B-cancer
, 7 8 503 504 O
participants 9 21 505 517 O
must 22 26 518 522 O
have 27 31 523 527 O
WBC 32 35 528 531 B-clinical_variable
< 36 37 532 533 O
15 38 40 534 536 B-upper_bound
Ã— 41 42 537 538 I-upper_bound
10 43 45 539 541 I-upper_bound
^ 45 46 541 542 I-upper_bound
9 46 47 542 543 I-upper_bound
/ 47 48 543 544 I-upper_bound
L 48 49 544 545 I-upper_bound

Known 0 5 546 551 O
prior 6 11 552 557 O
or 12 14 558 560 O
current 15 22 561 568 O
retinal 23 30 569 576 B-chronic_disease
or 31 33 577 579 I-chronic_disease
optic 34 39 580 585 I-chronic_disease
nerve 40 45 586 591 I-chronic_disease
disease 46 53 592 599 I-chronic_disease

Participant 0 11 600 611 O
is 12 14 612 614 O
candidate 15 24 615 624 O
for 25 28 625 628 O
hematopoietic 29 42 629 642 B-treatment
stem 43 47 643 647 I-treatment
cell 48 52 648 652 I-treatment
transplants 53 64 653 664 I-treatment
at 65 67 665 667 O
the 68 71 668 671 O
time 72 76 672 676 O
of 77 79 677 679 O
enrollment 80 90 680 690 O

Participants 0 12 691 703 O
with 13 17 704 708 O
AML 18 21 709 712 B-cancer

Participants 0 12 713 725 O
with 13 17 726 730 O
CMML 18 22 731 735 B-chronic_disease
must 23 27 736 740 O
have 28 32 741 745 O
been 33 37 746 750 O
treated 38 45 751 758 O
with 46 50 759 763 O
at 51 53 764 766 O
least 54 59 767 772 O
one 60 63 773 776 B-lower_bound
prior 64 69 777 782 I-lower_bound
therapy 70 77 783 790 B-treatment
( 78 79 791 792 O
hydroxyurea 79 90 792 803 B-treatment
or 91 93 804 806 O
a 94 95 807 808 O
hypomethylating 96 111 809 824 B-treatment
agent 112 117 825 830 I-treatment
[ 118 119 831 832 I-treatment
HMA 119 122 832 835 I-treatment
] 122 123 835 836 I-treatment
) 123 124 836 837 O

Participants 0 12 838 850 O
with 13 17 851 855 O
higher 18 24 856 862 O
- 24 25 862 863 O
risk 25 29 863 867 O
MDS 30 33 868 871 B-cancer
/ 33 34 871 872 O
CMML 34 38 872 876 B-cancer
must 39 43 877 881 O
be 44 46 882 884 O
intolerant 47 57 885 895 O
of 58 60 896 898 O
hypomethylating 61 76 899 914 B-treatment
agents 77 83 915 921 I-treatment
( 84 85 922 923 I-treatment
HMAs 85 89 923 927 I-treatment
) 89 90 927 928 I-treatment

Previously 0 10 929 939 O
treated 11 18 940 947 O
participants 19 31 948 960 O
should 32 38 961 967 O
have 39 43 968 972 O
evidence 44 52 973 981 O
of 53 55 982 984 O
persistent 56 66 985 995 O
or 67 69 996 998 O
recurrent 70 79 999 1008 O
AML 80 83 1009 1012 B-cancer
in 84 86 1013 1015 O
the 87 90 1016 1019 O
peripheral 91 101 1020 1030 O
blood 102 107 1031 1036 O
and/or 108 114 1037 1043 O
bone 115 119 1044 1048 O
marrow 120 126 1049 1055 O
that 127 131 1056 1060 O
is 132 134 1061 1063 O
refractory 135 145 1064 1074 O
to 146 148 1075 1077 O
, 148 149 1077 1078 O
or 150 152 1079 1081 O
has 153 156 1082 1085 O
relapsed 157 165 1086 1094 O
from 166 170 1095 1099 O
, 170 171 1099 1100 O
their 172 177 1101 1106 O
most 178 182 1107 1111 O
recent 183 189 1112 1118 O
prior 190 195 1119 1124 O
line 196 200 1125 1129 O
of 201 203 1130 1132 O
treatment 204 213 1133 1142 O

Retinitis 0 9 1143 1152 B-chronic_disease
Pigmentosa 10 20 1153 1163 I-chronic_disease

diabetic 0 8 1164 1172 B-chronic_disease
retinopathy 9 20 1173 1184 I-chronic_disease

have 0 4 1185 1189 O
serum 5 10 1190 1195 B-clinical_variable
EPO 11 14 1196 1199 I-clinical_variable
levels 15 21 1200 1206 I-clinical_variable
> 22 23 1207 1208 O
500 24 27 1209 1212 B-lower_bound
U 28 29 1213 1214 I-lower_bound
/ 29 30 1214 1215 I-lower_bound
L 30 31 1215 1216 I-lower_bound

optic 0 5 1217 1222 B-chronic_disease
neuritis 6 14 1223 1231 I-chronic_disease

